Information about Aglaia BioMedical Ventures
My details
*
*
*

Aglaia BioMedical Ventures (SRL)

KvK 34140330

Professor Bronkhorstlaan 10/G 92, 3723 MB Bilthoven

Company information

Status
Active

KVK number

KvK 34140330

VAT Number

NL 809086761 B01
Established
01-09-2000
Last balance sheet year
2024
Company size
Small 0 FTE
RSIN number
809086761
Principal activity
Natuurwetenschappelijk onderzoek en experimentele ontwikkeling
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Aglaia BioMedical Ventures

2024 2023 2022 2021
Equity € 658.462 199 % € 220.277 139 % € -561.220 -383 % € 198.569
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Aglaia BioMedical Ventures?
The KVK number of Aglaia BioMedical Ventures is KvK 34140330
What is the VAT number of Aglaia BioMedical Ventures?
The VAT number of Aglaia BioMedical Ventures is NL 809086761 B01.
Wat is the PEPPOL ID of Aglaia BioMedical Ventures?
There is no information available about the PEPPOL ID of Aglaia BioMedical Ventures or the company is not yet registered on the PEPPOL network.
When was Aglaia BioMedical Ventures founded?
Aglaia BioMedical Ventures was founded on 01-09-2000.
What is the address of Aglaia BioMedical Ventures?
The current registered office of Aglaia BioMedical Ventures is located at Professor Bronkhorstlaan 10/G 92, 3723 MB Bilthoven.
When was the last time Aglaia BioMedical Ventures filed their annual financial statements?
The most recent financial statements of Aglaia BioMedical Ventures were filed on 31-12-2024.
How many employees does Aglaia BioMedical Ventures have?
There are currently no employees working at Aglaia BioMedical Ventures or no workforce information is available.
What is the annual turnover of Aglaia BioMedical Ventures?
There is no turnover available for Aglaia BioMedical Ventures.

Sources